Sensyne Health (SENS)

Sector:

Health Care

Index:

FTSE AIM All-Share

163.50p
   
  • Change Today:
      0.50p
  • 52 Week High: 185.00p
  • 52 Week Low: 29.35p
  • Currency: UK Pounds
  • Shares Issued: 164.80m
  • Volume: 90,749
  • Market Cap: £269.45m
  • RiskGrade: 353

Sensyne Health gets UK approval for 'SYNE-COV' algorithm

By Josh White

Date: Monday 01 Mar 2021

LONDON (ShareCast) - (Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Monday that its 'SYNE-COV' machine learning algorithm for Covid-19 risk prediction has achieved regulatory approval for use in the UK.
The AIM-traded firm said SYNE-COV analyses more than 60 variables in the patient electronic health record to generate a prediction of the likelihood of a Covid-positive patient developing severe disease, requiring ventilation or admission to intensive care.

It said it provides the risk prediction, together with an explanation of the result, to help clinicians manage patients admitted to hospital with Covid infection.

The SYNE-COV product was developed in collaboration with the Chelsea and Westminster Hospitals NHS Foundation Trust, and was the first algorithm developed from the 'SENSE' clinical and operational algorithm engine to achieve UK regulatory approval.

SENSE generates clinical AI algorithms, called 'SYNEs', from the analysis of data in patient electronic health records to provide decision support to clinicians.

The company said it had several algorithms currently in development across a number of medical conditions, which, subject to regulatory approval, it intended to market to healthcare providers in the UK and internationally.

Following regulatory approval, Sensyne said it was now able to market SYNE-COV across the UK.

It was planning to market the algorithm to NHS trusts in order to help them with Covid-19 preparedness, and to deploy the algorithm in good time for the 2021-2022 winter season.

"This is the first Sensyne clinical AI algorithm to achieve regulatory approval that has been developed using our SENSE clinical AI platform," said chief executive officer Lord Drayson.

"The SENSE engine is expected to be able to generate clinical algorithms across a range of medical conditions that will provide real-time clinical decision making support.

"Achieving the first regulatory approval is an important milestone for the company, and we look forward to being able to roll SYNE-COV out to the NHS."

At 1105 GMT, shares in Sensyne Health were up 0.15% at 162.75p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Sensyne Health Market Data

Currency UK Pounds
Share Price 163.50p
Change Today 0.50p
% Change 0.31 %
52 Week High 185.00p
52 Week Low 29.35p
Volume 90,749
Shares Issued 164.80m
Market Cap £269.45m
RiskGrade 353

Sensyne Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.75% below the market average51.75% below the market average51.75% below the market average51.75% below the market average51.75% below the market average
58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average
Price Trend
25.31% above the market average25.31% above the market average25.31% above the market average25.31% above the market average25.31% above the market average
28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average
Income Not Available
Growth
46.44% above the market average46.44% above the market average46.44% above the market average46.44% above the market average46.44% above the market average
54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Sensyne Health Dividends

No dividends found

Trades for 06-May-2021

Time Volume / Share Price
16:24 8,134 @ 160.00p
15:54 604 @ 164.50p
15:42 2,997 @ 162.20p
15:22 4,852 @ 164.70p
14:22 2,805 @ 162.20p

Sensyne Health Key Personnel

CEO Paul Drayson

Top of Page